Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
Aim of this study will evaluate the efficacy and safety of zanubrutinib in combination with
R-CHOP for newly diagnosed untreated Non-GCB DLBCL Patients
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University